{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:59:01Z","timestamp":1787680741754,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1038\/sj.leu.2402330","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:45:09Z","timestamp":1031251509000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Thalidomide for the treatment of patients with myelodysplastic syndromes"],"prefix":"10.1038","volume":"16","author":[{"given":"C","family":"Strupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aivado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Misgeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Gattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,1,24]]},"reference":[{"key":"BF2402330_CR1","first-page":"110","volume-title":"Hematology","author":"CL Willman","year":"2000","unstructured":"Willman CL, Barrett AJ, Saunthararajah Y, Hellstr\u00f6m-Lindberg E . Achievements in understanding and treatment of myelodysplastic syndromes Hematology American Society of Hematology: Washington 2000 pp 110\u2013132"},{"key":"BF2402330_CR2","first-page":"177","volume":"46","author":"K Zwingenberger","year":"1995","unstructured":"Zwingenberger K, Wnendt S . Immunmodulation by thalidomide: systematic review of the literature and of unpublished results J Inflamm 1995\u20131996 46: 177\u2013211","journal-title":"J Inflamm"},{"key":"BF2402330_CR3","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1128\/AAC.44.9.2286-2290.2000","volume":"44","author":"A Verbon","year":"2000","unstructured":"Verbon A, Juffermans NP, Speelman P, van Deventer SJH, Ten Berge IJM, Guchelaar HJ, van der Poll T . A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans Antimicrobial agentschemother 2000 44: 2286\u20132290","journal-title":"Antimicrobial agentschemother"},{"key":"BF2402330_CR4","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","volume":"187","author":"PAJ Haslett","year":"1998","unstructured":"Haslett PAJ, Corrall LG, Albert M, Kaplan G . Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset J Exp Med 1998 187: 1885\u20131892","journal-title":"J Exp Med"},{"key":"BF2402330_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","volume":"99","author":"SM McHugh","year":"1995","unstructured":"McHugh SM, Rifkin IR, Deighton J, Wilson AB, Lachmann PJ, Lockwood CM, Ewan PW . The immunosuppressive drug thalidomide induces T helper cell type 2 (Th 2) and concomitantly inhibits Th 1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures Clin Exp Immunol 1995 99: 160\u2013167","journal-title":"Clin Exp Immunol"},{"key":"BF2402330_CR6","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato RJ, Loughnan MS, Flynn E, Folkman J . Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci USA 1994 91: 4082\u20134085","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402330_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0006-2952(98)00046-X","volume":"55","author":"KS Bauer","year":"1998","unstructured":"Bauer KS, Dixon SC, Figg WG . Inhibition of angiogenesis bythalidomide requires metabolic activation, which is species-dependent Biochem Pharmacol 1998 55: 1827\u20131834","journal-title":"Biochem Pharmacol"},{"key":"BF2402330_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeldis J, Barlogie B . Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 1999 341: 1565\u20131571","journal-title":"N Engl J Med"},{"key":"BF2402330_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/028418600750063604","volume":"39","author":"J Blade","year":"2000","unstructured":"Blade J, Esteve J . Treatment approaches for relapsing and refractory multiple myeloma Acta Oncol 2000 39: 843\u2013847","journal-title":"Acta Oncol"},{"key":"BF2402330_CR10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","volume":"96","author":"A Aguayo","year":"2000","unstructured":"Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M . Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 2000 96: 2240\u20132245","journal-title":"Blood"},{"key":"BF2402330_CR11","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/sj.bjc.6693515","volume":"81","author":"G Pruneri","year":"1999","unstructured":"Pruneri G, Bertolini F, Soglio D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F . Angiogenesis in myelodysplastic syndromes Br J Cancer 1999 81: 1398\u20131401","journal-title":"Br J Cancer"},{"key":"BF2402330_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0037-1963(00)90027-1","volume":"37","author":"J Barrett","year":"2000","unstructured":"Barrett J, Saunthararajah Y, Molldrem J . Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol 2000 37: 15\u201329","journal-title":"Semin Hematol"},{"key":"BF2402330_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0145-2126(91)90028-R","volume":"15","author":"MA Smith","year":"1991","unstructured":"Smith MA, Smith JG . The occurrence, subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study Leuk Res 1991 15: 597\u2013601","journal-title":"Leuk Res"},{"key":"BF2402330_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189\u2013199","journal-title":"Br J Haematol"},{"key":"BF2402330_CR15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J . International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 1997 89: 2079\u20132088","journal-title":"Blood"},{"key":"BF2402330_CR16","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, L\u00f6wenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL . Report of an international working group standardize response criteria for myelodysplastic syndromes Blood 2000 96: 3671\u20133674","journal-title":"Blood"},{"key":"BF2402330_CR17","first-page":"260b","volume":"96","author":"CMC Dourado","year":"2000","unstructured":"Dourado CMC, Seixas-Silva JA, Besa EC . Response to thalidomide in 9 patients with myelodysplastic syndromes: a promising treatment for early or post-chemotherapy in late forms of MDS Blood 2000 96: 260b","journal-title":"Blood"},{"key":"BF2402330_CR18","first-page":"146a","volume":"96","author":"S Mundle","year":"2000","unstructured":"Mundle S, Zorat F, Shetty V, Allampallam K, Alvi S, Lisak L, Little L, Dean L, Nascimben F, Ekbal M, DuRandt M, Broderick E, Venugopal P, Raza A . Biologic determinents of clinical response to thalidomide in myelodysplasia Blood 2000 96: 146a","journal-title":"Blood"},{"key":"BF2402330_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO;2-H","volume":"50","author":"A Raza","year":"2000","unstructured":"Raza A . Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes Microsc Res Tech 2000 50: 229\u2013235","journal-title":"Microsc Res Tech"},{"key":"BF2402330_CR20","first-page":"146a","volume":"96","author":"A Raza","year":"2000","unstructured":"Raza A, Lisak L, Little L, Ekbal M, duRandt M, Ali E, Nascimben F, Tareen M, Venugopal P . Thalidomide as single agent or in combination with topotecan, pentoxifylline and\/or enbrel in myelodysplastic syndromes (MDS) Blood 2000 96: 146a","journal-title":"Blood"},{"key":"BF2402330_CR21","first-page":"611a","volume":"94","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Aguayo A, Estey E, Albitar M, O'Brien S, Giles FJ, Beran M, Cortes J, Zeldis J, Keating MJ, Barlogie B, Kantarjian HM . Thalidomide as anti-angiogenesis therapy (RX) in refractory or relapsed leukemias Blood 1999 94: 611a","journal-title":"Blood"},{"key":"BF2402330_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0024-3205(94)90099-X","volume":"55","author":"A Nogueira","year":"1994","unstructured":"Nogueira A, Neubert R, Helge H, Neubert D . Thalidomide and the immune system 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells Life Sci 1994 55: 77\u201392","journal-title":"Life Sci"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402330","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:53:55Z","timestamp":1648763635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["BF2402330"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402330","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]},"assertion":[{"value":"27 February 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}